Skip to main content

France’s INPI Fee Hike Takes Effect on 1 April: This Is About More Than Higher Costs

France’s National Institute of Industrial Property (INPI) now expressly lists new fees “applicable from 1 April 2026” on its official tariffs page, with the most visible changes concentrated in PCT international patent filing items: EUR 1,428 for a paper filing of up to 30 sheets, EUR 1,213 for an electronic filing of up to 30 sheets, EUR 16 for each sheet from the 31st onward, a search fee of EUR 1,885, a transmission fee to WIPO of EUR 62, and EUR 15 for an official copy. At first glance, this may look like a routine administrative update about official charges becoming more expensive. In practice, however, for businesses that use the international patent route to support market entry, fundraising narratives, licensing discussions, and cross-border technology strategy, it is a signal that the timetable, budget logic, and sequencing of international protection are being rewritten.

The deeper significance is that this is not merely a rise in per-application cost. It is a reminder that the sensitivity of international filings to budget, route selection, and preparation quality is all increasing at the same time. Once filing, search, and Europe-related downstream costs move more visibly together, companies can no longer manage overseas patent strategy through a rough “file first, sort it out later” approach. The applicants best positioned to absorb the increase will be those who move search work, drafting discipline, market prioritisation, and internal approval upstream. For everyone else, the fee increase will quickly expose the cost of weak preparation.

Log in to continue reading

Full access is available to registered users only, including what the fee rise really changes in budget design, how PCT and European cost layers now interact more tightly, which applicants are under the most pressure, and what the next 90 days should look like for filing rhythm and internal decision-making.

1. This is not just a tariff update; it is a repricing of international patent entry

When people see news like this, the instinctive reaction is usually simple: official fees have gone up again. But the more important point is not the number in isolation. It is the threshold those numbers redraw. The newly highlighted INPI amounts are concentrated in the PCT international filing stage, and the PCT route has never been just a formality. It is often the opening move in a company’s attempt to turn a technical asset into multi-country protection, investor-facing credibility, licensing leverage, and future market access. Once the entry point becomes more expensive, the impact does not stop at legal spend. It reaches the starting line of internationalisation itself.

From a business perspective, the key consequence of a fee increase is usually not “how much more per file” but “which files will now be forced to justify their existence.” For years, some applicants treated the PCT route as a relatively comfortable way to delay hard decisions: secure the international filing date first, then decide later which countries really matter, whether the commercial case is strong enough, and how the budget should be allocated. As filing and search costs rise, that logic becomes harder to defend. Management will ask more direct questions earlier. Which inventions are genuinely international assets? Which filings are only suitable for domestic protection or a narrower regional route? Which technical projects should wait until the commercial case is less speculative? The fee change pulls those questions forward.

That is why this development should not be read merely as “France has become more expensive.” It should be read as a sharper market signal from the international patent system itself: international filing is not a default action, but a strategic action that now demands stronger internal proof. For high-R&D businesses with clear cross-border licensing or export plans, the increase may amount to little more than a budget reshuffle. For teams relying on broad filing habits, low-quality placeholders, or unclear commercial priorities, the space for ambiguity is shrinking.

2. What changes is not only budget, but filing timing, drafting quality, and country ranking

Finance teams will notice the fee increase first, but it may show up in workflow before it shows up in accounting. The first shift is timing. Some companies have been willing to move into the PCT stage while the invention package or commercial roadmap was still evolving, simply to keep options open. That becomes more difficult when the official price of entering the international phase is higher. Filing too early, with an immature specification or a strategy that still depends on later repair, looks less like prudent optionality and more like inefficient spend. Companies are therefore pushed to answer a harder question sooner: is this invention really ready for international protection, or is it still better treated as a domestic or limited-scope priority asset?

The second shift is drafting quality. On paper, electronic filing remains cheaper than paper filing. But the real economic difference is rarely the filing medium. It is whether the claims, structure, examples, and support are good enough to justify the cost of taking the invention onto an international track. Once the fee level rises, poor drafting becomes more visibly expensive. A weak PCT filing is not merely a bad legal document; it is an overpriced bad legal document that may later reveal support gaps, blurred protection boundaries, or weak alignment with commercial reality. In that sense, the increase drags the cost of poor drafting from the back end of future disputes into the front end of present budgeting.

The third shift is country ranking and route selection. For many businesses, the PCT route is not the destination but the corridor toward Europe, the United States, Canada, Japan, and other key jurisdictions. The official INPI page and the related European fee landscape applicable from 1 April 2026 make one thing clearer: applicants need a more precise explanation of what the France/Europe track is strategically supposed to achieve. Is it there to support a financing story? To strengthen future licensing negotiations? To protect export markets or partnership discussions? If that purpose cannot be explained cleanly, the fee rise will expose the inertia inside route selection.

3. For smaller innovators, the real pressure is not simply price, but the loss of cheap indecision

Larger companies can often absorb a rise in per-file cost because they already have portfolio discipline, external counsel coordination, and established criteria for entering multiple jurisdictions. The sharper pressure falls on smaller innovators, early-stage technology companies, and budget-sensitive teams that still want international reach. In the past, the PCT route often gave those applicants a relatively respectable way to buy time: spend a manageable amount now and preserve future country choices while the commercial picture develops. As the cost of doing that rises, the threshold for using that strategy rises too.

That does not mean smaller applicants should abandon international filing. It means they need to improve the hit rate of international filing. The applicants best placed in this environment will be those who can present stronger pre-filing searches, a clearer business path, and a sharper ranking of target markets. The danger is not the fee increase by itself. The danger is continuing to treat international filing as a standard move while failing to upgrade the front-end analysis that should justify it.

Seen from that angle, the fee rise acts as a quality filter. It does not automatically reward the biggest applicants; it rewards the most prepared, the most disciplined, and the most selective. For companies with maturing IP management, that may actually be positive. When explicit filing costs rise, low-quality filings, trend-driven filings, and stockpiled placeholders become harder to sustain. The international noise level may fall.

4. The next 90 days should be used to rebuild budgets, search practice, and filing priorities

The least useful response is to stop at “we know INPI fees went up.” The useful response is to translate the change into an internal action list. First, rebuild the PCT budget model so it no longer looks only at filing fees in isolation. Search fees, translation, outside counsel, later European steps, and national phase entry costs should sit in one chain of analysis. Management needs to see the whole path before deciding which projects deserve to move forward, which should be delayed, and which should shift to a narrower regional strategy.

Second, move pre-filing search work and drafting discipline earlier. Once fees are higher, an overlong specification, weak claims architecture, or loose invention framing is no longer a mere drafting flaw; it is a cost problem. Third, re-rank target countries. Many companies still rely on inertia when choosing where to go after the PCT stage. In a higher-cost environment, every major route choice needs a commercial rationale. Fourth, change the approval rhythm. If an international filing requires management sign-off, it should not arrive at the final deadline as a rushed legal request. It should arrive earlier as a strategic decision supported by competitive intelligence, technical value, and commercial logic.

So the real message here is not simply that official fees in France have become higher. It is that international patent strategy is becoming less tolerant of loose expansion and more favourable to prepared applicants. The sooner businesses adapt to that reality, the more likely they are to turn higher official fees into a better international portfolio rather than just another administrative expense.

This column is provided for general information only and does not constitute legal advice or a formal service opinion. Specific matters should be assessed case by case and against the latest laws, policies, official fee schedules, and administrative practice.

The content in this section is provided for general reference only and does not constitute legal advice or formal service recommendations. For any specific matter, please consider the particular facts of your case and refer to the latest laws, policies, and practices of the relevant authorities.